Maravai LifeSciences Holdings, Inc. (MRVI) vs Xencor, Inc. (XNCR)

Maravai LifeSciences Holdings, Inc. and Xencor, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Xencor, Inc. are of similar size ($1.8B and $1.8B). Maravai LifeSciences Holdings, Inc. grew revenue faster over the last twelve months: −5.03% against −28.6%. Maravai LifeSciences Holdings, Inc. has the higher net margin (−37.1% vs −155.6%) and the higher return on invested capital (−15.8% vs −288.7%). Across the 18 metrics below, Maravai LifeSciences Holdings, Inc. leads on 13 and Xencor, Inc. on 5.

Valuation

Metric MRVI XNCR Biotechnology median
P/E n/m n/m 8.50
P/S 4.81 16.58 9.71
P/B 2.83 3.46 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 5.32 13.38 9.21
Earnings yield (7.66%) (9.46%) (33.15%)
Free cash flow yield (3.57%) (12.02%) (25.50%)

Profitability

Metric MRVI XNCR Biotechnology median
Gross margin 34.89% 100.00% 65.16%
Operating margin (56.08%) (205.84%) 0.00%
Net margin (37.07%) (155.59%) 0.00%
Free cash flow margin (17.17%) (198.42%) 0.00%
Return on equity (18.79%) (29.07%) (56.36%)
Return on assets (10.31%) (20.36%) (48.04%)
Return on invested capital (15.83%) (288.71%) 0.00%

Growth

Metric MRVI XNCR Biotechnology median
Revenue growth (TTM) (5.03%) (28.56%) 6.02%
EPS growth (last fiscal year) 14.29% 65.36% 30.26%
Revenue growth, 5-year CAGR (8.15%) 0.47% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MRVI XNCR Biotechnology median
Debt to equity 0.50 0.00 0.00
Current ratio 4.05 6.39 4.72
Net debt to EBITDA (0.69) 2.51 0.96

Dividend

Metric MRVI XNCR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MRVI XNCR Biotechnology median
Market cap 1.84b 1.78b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack